サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413722

認知健康成分の世界市場、予測（～2030年）

Cognitive Health Ingredients Market Research Report Forecast till 2030
出版日: | 発行: Market Research Future | ページ情報: 英文 186 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
認知健康成分の世界市場、予測（～2030年）
出版日: 2024年01月15日
発行: Market Research Future
ページ情報: 英文 186 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場の概要

世界の認知健康成分の市場規模は、調査期間にCAGR 8.43％で堅調に成長すると予測されています。認知健康や加齢に伴う認知機能の衰えに対する関心や懸念が高まり、認知健康成分を含む製品への関心が拡大しています。さらに、この動向は多くの先進国における高齢化によっても後押しされており、認知健康向けの製品を求める購入者基盤の拡大を促しています。

認知健康に対する意識の拡大が、市場成長の重大な促進要因となっています。近年、精神の健康に対する人々の意識が大きく変化しています。高齢化が進み、アルツハイマー病や認知症のような認知問題が拡大する中、認知能力を維持することの重要性が人々の意識に浮上しました。

地域の分析

北米市場は2022年に34.86%を占め、評価機関にCAGRで8.03%の成長が予測されます。その丈夫な医療枠組みと認知的健康の重要性に対する認知の拡大により、米国が北米市場において確固たる地位を築いています。近年、高齢化と認知機能の衰えに対する懸念により、オメガ3系不飽和脂肪酸などの認知健康成分への関心が高まっています。

アジア太平洋市場では、老年人口の増加と生活様式の進化に伴い、購入者がより健康志向を強めており、認知能力を向上させる製品への関心が高まっています。

当レポートでは、世界の認知健康成分市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

    • 世界の認知健康成分市場：タイプ別
    • 世界の認知健康成分市場：最終用途別
    • 世界の認知健康成分市場：流通チャネル別
    • 世界の認知健康成分市場：地域別

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

  • イントロダクション
  • 促進要因
    • 認知健康に対する意識の向上
    • 世界中での老年人口の増加
    • 促進要因の影響の分析
  • 抑制要因
    • 認知健康成分に関する厳しい規制要件と承認
    • 特定の成分の潜在的な副作用や安全性の問題に関する懸念により、採用が抑制される
    • 抑制要因の影響の分析
  • 機会
    • 個別化栄養に対する需要の高まり
  • 世界経済に対するCOVID-19の影響
  • 世界の認知健康成分市場に対するCOVID-19の影響
  • サプライチェーンに対する影響
    • メーカーに対する影響
    • 原材料サプライヤーに対する影響
    • 流通/ロジスティクスに対する影響

第5章 市場要因の分析

  • サプライチェーン/バリューチェーン分析
    • 原材料のサプライヤー
    • 製造・包装
    • 流通・販売チャネル
    • 小売業者、エンドユーザー
  • ポーターのファイブフォース分析モデル

第6章 世界の認知健康成分市場：タイプ別

  • 概要
  • 世界の認知健康成分の市場規模、市場の推計と予測：タイプ別（2019年～2030年）

第7章 世界の認知健康成分市場：最終用途別

  • 概要
  • 世界の認知健康成分の市場規模、市場の推計と予測：最終用途別（2019年～2030年）

第8章 世界の認知健康成分市場：流通チャネル別

  • 概要
  • 世界の認知健康成分の市場規模、市場の推計と予測：流通チャネル別（2019年～2030年）

第9章 世界の認知健康成分市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア・ニュージーランド
    • その他のアジア太平洋
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • GCC諸国
    • トルコ
    • 北アフリカ
    • 南アフリカ

第10章 競合情勢

  • 競合の概要
  • 競合ベンチマーキング
  • 世界の認知健康成分市場の主要企業
  • 世界の認知健康成分市場における開発数のリーダー企業
  • 主な発展と成長戦略
    • 製品の発売/製品開発/承認
    • 拡張と買収/パートナーシップ

第11章 企業プロファイル

  • KEMIN INDUSTRIES, INC.
  • NEXIRA
  • ARLA FOOD INGREDIENTS GROUP
  • AUREA BIOLABS
  • BIORIGINAL FOOD & SCIENCE CORP
  • BIOTROPICS MALAYSIA BERHAD
  • NATURAL FACTORS NUTRITIONAL PRODUCTS LTD
  • NOW FOODS
  • INTELLIGENT LABS
  • BASF SE

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 27
  • TABLE 2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 40
  • TABLE 3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 42
  • TABLE 4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 44
  • TABLE 5 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY REGION, 2019-2030 (USD MILLION) 46
  • TABLE 6 NORTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 48
  • TABLE 7 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 48
  • TABLE 8 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 49
  • TABLE 9 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 49
  • TABLE 10 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 49
  • TABLE 11 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 50
  • TABLE 12 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 50
  • TABLE 13 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 50
  • TABLE 14 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 51
  • TABLE 15 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 51
  • TABLE 16 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 51
  • TABLE 17 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 52
  • TABLE 18 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 52
  • TABLE 19 EUROPE: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 54
  • TABLE 20 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 55
  • TABLE 21 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 55
  • TABLE 22 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 55
  • TABLE 23 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 56
  • TABLE 24 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 56
  • TABLE 25 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 56
  • TABLE 26 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 57
  • TABLE 27 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 57
  • TABLE 28 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 57
  • TABLE 29 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 58
  • TABLE 30 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 58
  • TABLE 31 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 58
  • TABLE 32 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 59
  • TABLE 33 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 59
  • TABLE 34 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 59
  • TABLE 35 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 60
  • TABLE 36 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 60
  • TABLE 37 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 60
  • TABLE 38 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 61
  • TABLE 39 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 61
  • TABLE 40 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 61
  • TABLE 41 ASIA PACIFIC: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 63
  • TABLE 42 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 64
  • TABLE 43 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 64
  • TABLE 44 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 64
  • TABLE 45 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 65
  • TABLE 46 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 65
  • TABLE 47 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 65
  • TABLE 48 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 66
  • TABLE 49 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 66
  • TABLE 50 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 66
  • TABLE 51 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 67
  • TABLE 52 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 67
  • TABLE 53 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 67
  • TABLE 54 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 68
  • TABLE 55 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 68
  • TABLE 56 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 68
  • TABLE 57 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 69
  • TABLE 58 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 69
  • TABLE 59 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 69
  • TABLE 60 SOUTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 71
  • TABLE 61 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 71
  • TABLE 62 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 71
  • TABLE 63 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 72
  • TABLE 64 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 72
  • TABLE 65 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 72
  • TABLE 66 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 73
  • TABLE 67 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 73
  • TABLE 68 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 73
  • TABLE 69 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 74
  • TABLE 70 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 74
  • TABLE 71 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 74
  • TABLE 72 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 75
  • TABLE 73 MIDDLE EAST & AFRICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 77
  • TABLE 74 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 77
  • TABLE 75 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 77
  • TABLE 76 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 78
  • TABLE 77 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 78
  • TABLE 78 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 78
  • TABLE 79 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 79
  • TABLE 80 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 79
  • TABLE 81 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 79
  • TABLE 82 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 80
  • TABLE 83 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 80
  • TABLE 84 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 80
  • TABLE 85 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 81
  • TABLE 86 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 81
  • TABLE 87 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 81
  • TABLE 88 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 82
  • TABLE 89 MAJOR PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • TABLE 90 THE MOST ACTIVE PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • TABLE 91 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 85
  • TABLE 92 EXPANSION/ACQUISITION/ PARTNERSHIP 85
  • TABLE 93 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED 86
  • TABLE 94 NEXIRA: PRODUCTS OFFERED 88
  • TABLE 95 NEXIRA: KEY DEVELOPMENTS 88
  • TABLE 96 ARLA FOOD INGREDIENTS GROUP: PRODUCTS OFFERED 91
  • TABLE 97 AUREA BIOLABS: PRODUCTS/SERVICES OFFERED 92
  • TABLE 98 BIORIGINAL FOOD & SCIENCE CORP: PRODUCTS/SERVICES OFFERED 94
  • TABLE 99 BIOTROPICS MALAYSIA BERHAD: PRODUCTS/SERVICES OFFERED 96
  • TABLE 100 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD: PRODUCTS OFFERED 98
  • TABLE 101 NOW FOODS: PRODUCTS/SERVICES OFFERED 100
  • TABLE 102 INTELLIGENT LABS: PRODUCTS OFFERED 102
  • TABLE 103 BASF SE: PRODUCTS OFFERED 105
  • TABLE 104 BASF SE: KEY DEVELOPMENTS 105

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 15
  • FIGURE 2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY TYPE 16
  • FIGURE 3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY END-USE 17
  • FIGURE 4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 18
  • FIGURE 5 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY REGION 19
  • FIGURE 6 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET: MARKET STRUCTURE 21
  • FIGURE 7 KEY BUYING CRITERIA OF COGNITIVE HEALTH INGREDIENTS 21
  • FIGURE 8 RESEARCH PROCESS OF MRFR 22
  • FIGURE 9 DRO ANALYSIS OF GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 28
  • FIGURE 10 DRIVERS IMPACT ANALYSIS: COGNITIVE HEALTH INGREDIENTS MARKET 30
  • FIGURE 11 RESTRAINTS IMPACT ANALYSIS: COGNITIVE HEALTH INGREDIENTS MARKET 31
  • FIGURE 12 SUPPLY / VALUE CHAIN: GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 35
  • FIGURE 13 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 36
  • FIGURE 14 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE, 2022 (% SHARE) 38
  • FIGURE 15 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE, 2019 TO 2030 (USD MILLION) 39
  • FIGURE 16 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE, 2022 (% SHARE) 41
  • FIGURE 17 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE, 2019 TO 2030 (USD MILLION) 42
  • FIGURE 18 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL, 2022 (% SHARE) 43
  • FIGURE 19 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2030 (USD MILLION) 44
  • FIGURE 20 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION, 2022 TO 2030 (USD MILLION) 45
  • FIGURE 21 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION, 2022 (% SHARE) 46
  • FIGURE 22 NORTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 48
  • FIGURE 23 EUROPE: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 54
  • FIGURE 24 ASIA PACIFIC: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 63
  • FIGURE 25 SOUTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 70
  • FIGURE 26 MIDDLE EAST & AFRICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 76
  • FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 83
  • FIGURE 28 KEMIN INDUSTRIES, INC.: SWOT ANALYSIS 87
  • FIGURE 29 NEXIRA: SWOT ANALYSIS 89
  • FIGURE 30 ARLA FOOD INGREDIENTS GROUP: FINANCIAL OVERVIEW SNAPSHOT 90
  • FIGURE 31 ARLA FOOD INGREDIENTS GROUP: SWOT ANALYSIS 91
  • FIGURE 32 AUREA BIOLABS: SWOT ANALYSIS 93
  • FIGURE 33 BIORIGINAL FOOD & SCIENCE CORP: SWOT ANALYSIS 95
  • FIGURE 34 BIOTROPICS MALAYSIA BERHAD: SWOT ANALYSIS 97
  • FIGURE 35 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD: SWOT ANALYSIS 99
  • FIGURE 36 NOW FOODS: SWOT ANALYSIS 101
  • FIGURE 37 INTELLIGENT LABS: SWOT ANALYSIS 103
  • FIGURE 38 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 104
  • FIGURE 39 BASF SE: SWOT ANALYSIS 105
目次
Product Code: MRFR/F-B & N/5095-CR

Market Overview

Global Cognitive Health Ingredients Market is projected to register a healthy CAGR of 8.43% during the review period. The worldwide cognitive health ingredients market has encountered dynamic changes as of late determined by a few key variables. The developing mindfulness and concern in regard to cognitive health and age-related cognitive decay have filled expanded interest for items containing cognitive health ingredients. This pattern has been additionally advanced by the maturing populace in many created nations, prompting a bigger purchaser base looking for cognitive health arrangements.

Expanding consciousness of cognitive health is a vital driver behind the development of the worldwide cognitive health ingredients market. Throughout recent years, there has been a huge change in individuals' discernments in regard to mind health. With a maturing populace and expanding examples of cognitive issues like Alzheimer's illness and dementia, the significance of keeping up with cognitive capability has come to the very front of public awareness.

This elevated mindfulness is a consequence of expanded schooling and data largely spread about cognitive health. The web, online entertainment, and customary media channels play had a vital impact in spreading information about the meaning of cerebrum health. People are presently more proactive in looking for ways of improving and save their cognitive capacities, and this has converted into a flood popular for cognitive health items and ingredients.

Market Segmentation

The global cognitive health ingredients market segmentation is based on the type, such as omega-3 fatty acids, B-vitamins, vitamin E, citicoline, caffeine, adaptogens, and others.

Based on end-use the market is classified into human nutrition products, and animal nutrition products. The distribution channels segment includes direct and indirect.

Regional Analysis

The North America cognitive health ingredients market represented 34.86% in 2022 and is expected to develop with a CAGR of 8.03% during the assessed years. The US stands firm on a conspicuous footing in the North American cognitive health ingredients market because of its vigorous healthcare framework and developing familiarity with the significance of cognitive health. As of late, there has been a rising interest for cognitive health ingredients, like omega-3 unsaturated fats, cell reinforcements, and nutrients, driven by the maturing populace and worries about cognitive decay.

Europe is ready to rise to the place of the third-biggest worldwide market for food supplements, following Asia-Pacific and North America. According to information from Food Enhancements Europe, a critical 52% of European customers settle on dietary enhancements to maintain their general prosperity.

The Asia Pacific cognitive health ingredients market is encountering significant development driven by an expanded spotlight on mental prosperity. With a blossoming maturing populace and evolving ways of life, buyers in the region are turning out to be more health-cognizant, filling the interest in items that upgrade cognitive capabilities. Customary ingredients like ginseng and turmeric have acquired ubiquity for their cognitive advantages.

Market Overview

Key Companies in the Cognitive Health Ingredients market include Kemin Industries, Inc. (US), Nexira (France), Arla Food Ingredients Group (Denmark), Aurea Biolabs (India), Bioriginal Food & Science Corp (Canada), Biotropics Malaysia Berhad (Malaysia), Natural Factors Nutritional Products Ltd (Canada), NOW Foods (US), Intelligent Labs (UK), and BASF SE (Germany).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

    • 1.1.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 16
    • 1.1.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 17
    • 1.1.3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 18
    • 1.1.4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 19

2 MARKET INTRODUCTION 20

  • 2.1 DEFINITION 20
  • 2.2 SCOPE OF THE STUDY 20
  • 2.3 MARKET STRUCTURE 21
  • 2.4 KEY BUYING CRITERIA 21

3 RESEARCH METHODOLOGY 22

  • 3.1 RESEARCH PROCESS 22
  • 3.2 PRIMARY RESEARCH 23
  • 3.3 SECONDARY RESEARCH 24
  • 3.4 MARKET SIZE ESTIMATION 24
  • 3.5 TOP DOWN & BOTTOM-UP APPROACH 25
  • 3.6 FORECAST MODEL 26
  • 3.7 LIST OF ASSUMPTIONS 27

4 MARKET DYNAMICS 28

  • 4.1 INTRODUCTION 28
  • 4.2 DRIVERS 29
    • 4.2.1 INCREASING AWARENESS OF COGNITIVE HEALTH 29
    • 4.2.2 GROWING AGING POPULATION WORLDWIDE 29
    • 4.2.3 DRIVERS IMPACT ANALYSIS 30
  • 4.3 RESTRAINTS 30
    • 4.3.1 STRINGENT REGULATORY REQUIREMENTS AND APPROVALS IN THE COGNITIVE HEALTH INGREDIENTS 30
    • 4.3.2 CONCERNS REGARDING POTENTIAL SIDE EFFECTS OR SAFETY ISSUES OF CERTAIN INGREDIENTS LIMIT ADOPTION 31
    • 4.3.3 RESTRAINTS IMPACT ANALYSIS 31
  • 4.4 OPPORTUNITIES 32
    • 4.4.1 GROWING DEMAND FOR PERSONALIZED NUTRITION 32
  • 4.5 IMPACT OF COVID-19 ON GLOBAL ECONOMY 32
  • 4.6 IMPACT OF COVID-19 ON THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 33
  • 4.7 SUPPLY CHAIN IMPACT 34
    • 4.7.1 IMPACT ON MANUFACTURER 34
    • 4.7.2 IMPACT ON RAW MATERIAL SUPPLIER 34
    • 4.7.3 IMPACT ON DISTRIBUTION/LOGISTICS 34

5 MARKET FACTOR ANALYSIS 35

  • 5.1 SUPPLY/VALUE CHAIN ANALYSIS 35
    • 5.1.1 RAW MATERIALS SUPPLIERS 35
    • 5.1.2 MANUFACTURING & PACKAGING 35
    • 5.1.3 DISTRIBUTION & SALES CHANNEL 36
    • 5.1.4 RETAILERS AND END-USERS 36
  • 5.2 PORTER'S FIVE FORCES MODEL 36
    • 5.2.1 THREAT OF NEW ENTRANTS 37
    • 5.2.2 BARGAINING POWER OF SUPPLIERS 37
    • 5.2.3 BARGAINING POWER OF BUYERS 37
    • 5.2.4 THREAT OF SUBSTITUTES 37
    • 5.2.5 INTENSITY OF RIVALRY 37

6 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 38

  • 6.1 OVERVIEW 38
  • 6.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
    • 6.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40

7 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 41

  • 7.1 OVERVIEW 41
  • 7.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42
    • 7.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42

8 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 43

  • 8.1 OVERVIEW 43
  • 8.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44
    • 8.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44

9 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 45

  • 9.1 OVERVIEW 45
  • 9.2 NORTH AMERICA 47
    • 9.2.1 U.S. 49
    • 9.2.2 CANADA 50
    • 9.2.3 MEXICO 51
  • 9.3 EUROPE 53
    • 9.3.1 GERMANY 56
    • 9.3.2 FRANCE 57
    • 9.3.3 UK 58
    • 9.3.4 ITALY 59
    • 9.3.5 SPAIN 60
    • 9.3.6 REST OF EUROPE 61
  • 9.4 ASIA PACIFIC 62
    • 9.4.1 CHINA 65
    • 9.4.2 INDIA 66
    • 9.4.3 JAPAN 67
    • 9.4.4 AUSTRALIA & NEW ZEALAND 68
    • 9.4.5 REST OF ASIA PACIFIC 69
  • 9.5 SOUTH AMERICA 70
    • 9.5.1 BRAZIL 72
    • 9.5.2 ARGENTINA 73
    • 9.5.3 REST OF SOUTH AMERICA 74
  • 9.6 MIDDLE EAST & AFRICA 76
    • 9.6.1 GCC COUNTRIES 78
    • 9.6.2 TURKEY 79
    • 9.6.3 NORTHERN AFRICA 80
    • 9.6.4 SOUTHERN AFRICA 81

10 COMPETITIVE LANDSCAPE 83

  • 10.1 COMPETITIVE OVERVIEW 83
  • 10.2 COMPETITIVE BENCHMARKING 83
  • 10.3 MAJOR PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • 10.4 LEADING PLAYERS IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 85
    • 10.5.1 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 85
    • 10.5.2 EXPANSION/ACQUISITION/ PARTNERSHIP 85

11 COMPANY PROFILES 86

  • 11.1 KEMIN INDUSTRIES, INC. 86
    • 11.1.1 COMPANY OVERVIEW 86
    • 11.1.2 FINANCIAL OVERVIEW 86
    • 11.1.3 PRODUCTS OFFERED 86
    • 11.1.4 KEY DEVELOPMENTS 86
    • 11.1.5 SWOT ANALYSIS 87
    • 11.1.6 KEY STRATEGIES 87
  • 11.2 NEXIRA 88
    • 11.2.1 COMPANY OVERVIEW 88
    • 11.2.2 FINANCIAL OVERVIEW 88
    • 11.2.3 PRODUCTS OFFERED 88
    • 11.2.4 KEY DEVELOPMENTS 88
    • 11.2.5 SWOT ANALYSIS 89
    • 11.2.6 KEY STRATEGIES 89
  • 11.3 ARLA FOOD INGREDIENTS GROUP 90
    • 11.3.1 COMPANY OVERVIEW 90
    • 11.3.2 FINANCIAL OVERVIEW 90
    • 11.3.3 PRODUCTS OFFERED 91
    • 11.3.4 KEY DEVELOPMENTS 91
    • 11.3.5 SWOT ANALYSIS 91
    • 11.3.6 KEY STRATEGIES 91
  • 11.4 AUREA BIOLABS 92
    • 11.4.1 COMPANY OVERVIEW 92
    • 11.4.2 FINANCIAL OVERVIEW 92
    • 11.4.3 PRODUCTS/SERVICES OFFERED 92
    • 11.4.4 KEY DEVELOPMENTS 92
    • 11.4.5 SWOT ANALYSIS 93
    • 11.4.6 KEY STRATEGIES 93
  • 11.5 BIORIGINAL FOOD & SCIENCE CORP 94
    • 11.5.1 COMPANY OVERVIEW 94
    • 11.5.2 FINANCIAL OVERVIEW 94
    • 11.5.3 PRODUCTS/SERVICES OFFERED 94
    • 11.5.4 KEY DEVELOPMENTS 94
    • 11.5.5 SWOT ANALYSIS 95
    • 11.5.6 KEY STRATEGIES 95
  • 11.6 BIOTROPICS MALAYSIA BERHAD 96
    • 11.6.1 COMPANY OVERVIEW 96
    • 11.6.2 FINANCIAL OVERVIEW 96
    • 11.6.3 PRODUCTS/SERVICES OFFERED 96
    • 11.6.4 KEY DEVELOPMENTS 96
    • 11.6.5 SWOT ANALYSIS 97
    • 11.6.6 KEY STRATEGIES 97
  • 11.7 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD 98
    • 11.7.1 COMPANY OVERVIEW 98
    • 11.7.2 FINANCIAL OVERVIEW 98
    • 11.7.3 PRODUCTS/SERVICES OFFERED 98
    • 11.7.4 KEY DEVELOPMENTS 98
    • 11.7.5 SWOT ANALYSIS 99
    • 11.7.6 KEY STRATEGIES 99
  • 11.8 NOW FOODS 100
    • 11.8.1 COMPANY OVERVIEW 100
    • 11.8.2 FINANCIAL OVERVIEW 100
    • 11.8.3 PRODUCTS/SERVICES OFFERED 100
    • 11.8.4 KEY DEVELOPMENTS 100
    • 11.8.5 SWOT ANALYSIS 101
    • 11.8.6 KEY STRATEGIES 101
  • 11.9 INTELLIGENT LABS 102
    • 11.9.1 COMPANY OVERVIEW 102
    • 11.9.2 FINANCIAL OVERVIEW 102
    • 11.9.3 PRODUCTS OFFERED 102
    • 11.9.4 KEY DEVELOPMENTS 102
    • 11.9.5 SWOT ANALYSIS 103
    • 11.9.6 KEY STRATEGIES 103
  • 11.10 BASF SE 104
    • 11.10.1 COMPANY OVERVIEW 104
    • 11.10.2 FINANCIAL OVERVIEW 104
    • 11.10.3 PRODUCTS OFFERED 105
    • 11.10.4 KEY DEVELOPMENTS 105
    • 11.10.5 SWOT ANALYSIS 105
    • 11.10.6 KEY STRATEGIES 106

12 APPENDIX 107

  • 12.1 REFERENCES 107